302 related articles for article (PubMed ID: 22363635)
21. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
22. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
23. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
[TBL] [Abstract][Full Text] [Related]
25. α-Mangostin Regulates Hepatic Steatosis and Obesity through SirT1-AMPK and PPARγ Pathways in High-Fat Diet-Induced Obese Mice.
Choi YH; Bae JK; Chae HS; Kim YM; Sreymom Y; Han L; Jang HY; Chin YW
J Agric Food Chem; 2015 Sep; 63(38):8399-406. PubMed ID: 26368128
[TBL] [Abstract][Full Text] [Related]
26. Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
Pharmacol Rep; 2012; 64(1):140-9. PubMed ID: 22580530
[TBL] [Abstract][Full Text] [Related]
27. [Effect of exendin-4 on lipid deposition in skeletal muscle of diet-induced obese mice and its underlying mechanism].
Cao HY; Xu F; Chen ZL; Lin BS; Zheng XB; Yuan SH; Liang H; Weng JP
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):131-136. PubMed ID: 28088959
[No Abstract] [Full Text] [Related]
28. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
Baggio LL; Huang Q; Cao X; Drucker DJ
Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-like peptide 1 inhibits the sirtuin deacetylase SirT1 to stimulate pancreatic β-cell mass expansion.
Bastien-Dionne PO; Valenti L; Kon N; Gu W; Buteau J
Diabetes; 2011 Dec; 60(12):3217-22. PubMed ID: 22013015
[TBL] [Abstract][Full Text] [Related]
30. α-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase.
Chen WL; Kang CH; Wang SG; Lee HM
Diabetologia; 2012 Jun; 55(6):1824-35. PubMed ID: 22456698
[TBL] [Abstract][Full Text] [Related]
31. The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis.
Gupta NA; Kolachala VL; Jiang R; Abramowsky C; Romero R; Fifadara N; Anania F; Knechtle S; Kirk A
Am J Pathol; 2012 Nov; 181(5):1693-701. PubMed ID: 22960075
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of exendin-4-induced steatosis by protein kinase A in cultured HepG2 human hepatoma cells.
Chen-Liaw AY; Hammel G; Gomez G
In Vitro Cell Dev Biol Anim; 2017 Sep; 53(8):721-727. PubMed ID: 28707223
[TBL] [Abstract][Full Text] [Related]
33. Taurine Activates SIRT1/AMPK/FOXO1 Signaling Pathways to Favorably Regulate Lipid Metabolism in C57BL6 Obese Mice.
Karikkakkavil Prakashan AD; Muthukumar SP; Martin A
Mol Nutr Food Res; 2024 Apr; 68(8):e2200660. PubMed ID: 38549461
[TBL] [Abstract][Full Text] [Related]
34. Berbamine induced activation of the SIRT1/LKB1/AMPK signaling axis attenuates the development of hepatic steatosis in high-fat diet-induced NAFLD rats.
Sharma A; Anand SK; Singh N; Dwarkanath A; Dwivedi UN; Kakkar P
Food Funct; 2021 Jan; 12(2):892-909. PubMed ID: 33411880
[TBL] [Abstract][Full Text] [Related]
35. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.
Shen Z; Liang X; Rogers CQ; Rideout D; You M
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G364-74. PubMed ID: 20007851
[TBL] [Abstract][Full Text] [Related]
36. Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration.
Wang Y; Parlevliet ET; Geerling JJ; van der Tuin SJ; Zhang H; Bieghs V; Jawad AH; Shiri-Sverdlov R; Bot I; de Jager SC; Havekes LM; Romijn JA; Willems van Dijk K; Rensen PC
Br J Pharmacol; 2014 Feb; 171(3):723-34. PubMed ID: 24490861
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
[TBL] [Abstract][Full Text] [Related]
38. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
39. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
40. Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1.
Cheng B; Gao W; Wu X; Zheng M; Yu Y; Song C; Miao W; Yang Z; He Y; Liu C; Yang W; Yang X; Li Y; Zhang F; Gao Y
J Agric Food Chem; 2020 Apr; 68(14):4215-4226. PubMed ID: 32181656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
